Comparable end-point dilutions were obtained with both the solution and surface versions of the α-synuclein and tau RT-QuIC assays when seeded with DLB (Fig 4A and 4B) or sAD (Fig 4C and 4D) brain homogenates, respectively. This evidence concerns the gene MAPT and Lewy body dementia.